YT 6-2 是一种针对p62/SQSTM1的自噬靶向配体 (ATL),适用于合成AUTOTAC降解剂ATC-324。ATC-324 通过促进 AR/p62 复合物的形成,使 AR 经由自噬-溶酶体途径降解。它能够降低核内 AR 水平,下调 AR 和 AR-v7 相关靶基因的表达,并对前列腺癌(PCa)中常见的 AR 突变体产生降解效果。
iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1. iRucaparib-AP6 is a highly efficient and specific PARP1 degrader based on Rucaparib by using the PROTAC approach.
6-Bromohexylphosphonic acid is an alkyl chain-based linker commonly employed in the synthesis of PROTACs, which stands for proteolysis targeting chimeras[1].
Acid-PEG6-C2-Boc is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.
Ald-Ph-PEG6-acid is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.